EQANIE Competitors

BrainCo’s leadership draws on deep experience in neuroscience research and expertise in education to deliver entirely new applications of brainwave technology in the education, wellness, and research spaces. We’ve learned important lessons as we’ve grown from a small team in an apartment basement to over 100 employees in 4 offices around the world. Since 2015 we’ve been working on providing the best experience possible for our customers and we’re here to share our progress and innovations with you.

Neurotrack is a cognitive care enablement platform that helps health systems, Medicare Advantage plans, ACOs, and value-based primary care groups find and diagnose cognitive impairment earlier. Dementia goes undiagnosed in primary care at alarming rates. Neurotrack gives care teams a practical way to change that at scale. Providers use our science-backed digital cognitive screening and assessment during routine care, including the Medicare Annual Wellness Visit (AWV), and patients can complete it in clinic or at home. Results are scored automatically and connect to a structured clinical pathway and patient-specific care plans through Smart Logic™, our proprietary clinical decision support engine. This helps primary care teams move from a positive screen to a confident dementia diagnosis and clear next steps. Neurotrack integrates with leading EHRs, including Epic and athenahealth, so results flow directly into the patient record and clinical workflow. We also support providers with CME courses and patient education resources. Neurotrack has published 27 peer-reviewed papers, holds 11 patents, and is registered as an FDA Class II medical device. Learn more at neurotrack.com.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.